Identifying and Screening for Hepatic Encephalopathy Risk Factors

Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, delve into the complexities of hepatic encephalopathy, exploring the various risk factors that contribute to its development, such as alcohol-induced cirrhosis, sarcopenia, CNS medications, opioids, and other potential triggers.

Now Viewing

EP: 1.Identifying and Screening for Hepatic Encephalopathy Risk Factors

EP: 2.Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care

EP: 3.Implementing Evidence-Based Guidelines for Hepatic Encephalopathy Management

EP: 4.Addressing the Caregiver Burden in Hepatic Encephalopathy Management

EP: 5.Optimizing Care for Newly Diagnosed Hepatic Encephalopathy

EP: 6.Enhancing Hepatic Encephalopathy Care through Pharmacist-Prescriber Collaboration

EP: 7.Managing Adverse Events Associated with HE Therapies

EP: 8.Integrating Treatment Protocols and Community Pharmacy in HE Management

EP: 9.Promoting Adherence: Strategies for Maintaining HE Therapy

EP: 10.Empowering Pharmacists: Essential Insights for HE Management

EP: 11.Optimizing Transitions of Care for Hepatic Encephalopathy Patients

EP: 12.Collaborative Care: Key Stakeholders in HE Treatment and Recovery

EP: 13.Hepatic Encephalopathy: Critical Insights and Closing Thoughts

Related Videos

Related Content

Advertisement

March 4th 2024

Integration of DBS Shows Promise Identifying Dysfunctional Brain Circuits, Treating Brain Disorders

Gillian McGovern, Associate Editor

February 5th 2024

Study Results Highlight Importance of Overcoming Stigma When Addressing Brain Health

Gillian McGovern, Associate Editor

January 22nd 2024

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health

Gillian McGovern, Associate Editor

January 15th 2024

Individuals With Obesity More Likely to Have MGUS, A Multiple Myeloma Precursor

Gillian McGovern, Associate Editor

January 9th 2024

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

Gillian McGovern, Associate Editor

January 9th 2024

Study Data Show Telemedicine Endocrinology Care Not as Effective as In-Person Care

Erin Hunter, Associate Editor

Related Content

Advertisement

March 4th 2024

Integration of DBS Shows Promise Identifying Dysfunctional Brain Circuits, Treating Brain Disorders

Gillian McGovern, Associate Editor

February 5th 2024

Study Results Highlight Importance of Overcoming Stigma When Addressing Brain Health

Gillian McGovern, Associate Editor

January 22nd 2024

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health

Gillian McGovern, Associate Editor

January 15th 2024

Individuals With Obesity More Likely to Have MGUS, A Multiple Myeloma Precursor

Gillian McGovern, Associate Editor

January 9th 2024

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

Gillian McGovern, Associate Editor

January 9th 2024

Study Data Show Telemedicine Endocrinology Care Not as Effective as In-Person Care

Erin Hunter, Associate Editor